Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05446584

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.

Detailed description

Ten study visits will be completed by each participant. The initial visit will include a blood draw and a baseline memory evaluation. Afterwards, participants will be randomized to begin with one of 3 conditions of HD-tDCS. The three conditions are sham-control, active stimulation to frontal region, and active stimulation to left temporal region. All participants will be expected to completed each HD-tDCS condition, which will be counterbalanced and separated by 14 days. Active HD-tDCS will be applied at 2 mA for 30 minutes over 3 consecutive daily sessions while sham stimulation will be applied for the same duration and timespan. All subjects will complete memory assessments again immediately following each HD-tDCS condition for a total of four test sessions.

Conditions

Interventions

TypeNameDescription
DEVICEHigh Definition Transcranial Direct Current StimulationHD-tDCS for this study is not intended to be a treatment, and will be applied continuously for 30 minutes at sham (0 mA) or 2 mA for active conditions across 3 consecutive daily sessions to probe neural circuit integrity. This specific HD-tDCS device is completely computer driven, running on a laptop using specialized software. Circular electrodes (12-mm in diameter) filled with conductive gel will be placed in a 4x1 ring configuration with the central electrode being the anode surrounded by four cathodes.

Timeline

Start date
2023-04-20
Primary completion
2027-05-01
Completion
2027-05-31
First posted
2022-07-06
Last updated
2025-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05446584. Inclusion in this directory is not an endorsement.